alpha 1-Antitrypsin (alpha 1AT) deficiency is a hereditary disorder associated with reduced serum alpha 1AT levels and the development of pulmonary emphysema. An alpha 1AT gene is defined as "Null" when no alpha 1AT in serum is attributed to that alpha 1AT gene. Although all alpha 1AT Null genes have identical phenotypic consequences (i.e. no detectable alpha 1AT in the serum), different genotypic mechanisms can cause the Null state. This study defines the molecular basis for the alpha 1AT gene Nullmattawa, identified and cloned from genomic DNA of an individual with the Null-Null phenotype and emphysema resulting from the heterozygous inheritance of the Nullmattawa and Nullbellingham genes. Sequencing of exons Ic-V and all exon-intron junctions of the Nullmattawa gene demonstrated it was identical to the common normal M1(Val213) alpha 1AT gene except for the insertion of a single nucleotide within the coding region of exon V, causing a 3' frameshift with generation of a premature stop signal. Family analysis using oligonucleotide probes specific for the Nullmattawa sequence demonstrated the gene was inherited in an autosomal fashion. Examination of blood monocytes demonstrated that a normal-sized, 1.8-kb alpha 1AT mRNA transcript is associated with the Nullmattawa gene and in vitro translation of mRNA with the Nullmattawa mutation showed it translated at a normal rate but produced a truncated alpha 1AT protein. Additionally, retroviral transfer of the alpha 1AT Nullmattawa cDNA to murine fibroblasts demonstrated no detectable intracellular or secreted alpha 1AT, despite the presence of alpha 1AT Nullmattawa mRNA transcripts. These findings are consistent with the concept that the molecular pathophysiology of Nullmattawa is likely manifested at a posttranslational level. The identification of the Nullmattawa gene supports the concept that Null alpha 1AT alleles represent a heterogenous group in which very different mechanisms cause the identical phenotypic state.
D Curiel, M Brantly, E Curiel, L Stier, R G Crystal
Title and authors | Publication | Year |
---|---|---|
Ferret models of alpha-1 antitrypsin deficiency develop lung and liver disease
Nan He, Xiaoming Liu, Amber R Vegter, T. Idil Evans, Jaimie S Gray, Junfeng Guo, Shashanna R Moll, Lydia J Guo, Meihui Luo, Ningxia Ma, Xingshen Sun, Bo Liang, Ziying Yan, Zehua Feng, Lisi Qi, Arnav S. Joshi, Weam Shahin, Yaling Yi, Katherine N Gibson-Corley, Eric A Hoffman, Kai Wang, Christian Mueller, John F Engelhardt, Bradley H Rosen |
JCI Insight | 2022 |
Known Mutations at the Cause of Alpha-1 Antitrypsin Deficiency an Updated Overview of SERPINA1 Variation Spectrum
S Seixas, PI Marques |
The Application of Clinical Genetics | 2021 |
Variants of SERPINA1 and the increasing complexity of testing for alpha-1 antitrypsin deficiency
KE Foil |
Therapeutic Advances in Chronic Disease | 2021 |
The Clinical Utility of Determining the Allelic Background of Mutations Causing Alpha-1 Antitrypsin Deficiency: The Case with the Null Variant Q0(Mattawa)/Q0(Ourém)
J Bellemare, N Gaudreault, K Valette, I Belmonte, A Nuñez, M Miravitlles, F Maltais, Y Bossé |
Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation | 2021 |
Identification of Variants in Alpha-1-Antitrypsin by High Resolution Melting
G Bidla, DS Rosenblatt, BM Gilfix |
2020 | |
Alpha-1-antitrypsin deficiency: Genetic variations, clinical manifestations and therapeutic interventions
YM Hazari, A Bashir, M Habib, S Bashir, H Habib, MA Qasim, NN Shah, E Haq, J Teckmane, KM Fazili |
Mutation Research/Reviews in Mutation Research | 2017 |
Novel variants of SERPIN1A gene: Interplay between alpha1-antitrypsin deficiency and chronic obstructive pulmonary disease
A Bashir, NN Shah, YM Hazari, M Habib, S Bashir, N Hilal, M Banday, S Asrafuzzaman, KM Fazili |
Respiratory Medicine | 2016 |
Alpha-1-antitrypsin (SERPINA1) mutation spectrum: Three novel variants and haplotype characterization of rare deficiency alleles identified in Portugal
D Silva, MJ Oliveira, M Guimarães, R Lima, S Gomes, S Seixas |
Respiratory Medicine | 2016 |
Animal Models of Chronic Obstructive Pulmonary Disease
S Pérez-Rial, Á Girón-Martínez, G Peces-Barba |
Archivos de Bronconeumología (English Edition) | 2015 |
Can we change a genetically determined future?
LR Fernandes, LV Rodrigues, F Costa, Y Martins |
BMJ case reports | 2015 |
Severe alpha-1 antitrypsin deficiency in composite heterozygotes inheriting a new splicing mutation QOMadrid
B Lara, MT Martínez, I Blanco, C Hernández-Moro, EA Velasco, I Ferrarotti, F Rodriguez-Frias, L Perez, I Vazquez, J Alonso, M Posada, B Martínez-Delgado |
Respiratory Research | 2014 |
Identification and characterisation of eight novel SERPINA1 Null mutations
I Ferrarotti, TP Carroll, S Ottaviani, AM Fra, G O’Brien, K Molloy, L Corda, D Medicina, DR Curran, NG McElvaney, M Luisetti |
Orphanet Journal of Rare Diseases | 2014 |
Modelos animales de enfermedad pulmonar obstructiva crónica
S Pérez-Rial, Á Girón-Martínez, G Peces-Barba |
Archivos de Bronconeumología | 2014 |
Déficit de alfa-1-antitripsina asociado a la variante Matawa
B Lara, B Martínez-Delgado, ML Torres, S Marín-Arguedas, A Bustamante, M Miravitlles |
Archivos de Bronconeumología | 2013 |
Alpha-1-Antitrypsin Deficiency Associated With the Mattawa Variant
B Lara, B Martínez-Delgado, ML Torres, S Marín-Arguedas, A Bustamante, M Miravitlles |
Archivos de Bronconeumología (English Edition) | 2013 |
Coordinated DNA methylation and gene expression changes in smoker alveolar macrophages: specific effects on VEGF receptor 1 expression
RA Philibert, RA Sears, LS Powers, E Nash, T Bair, AK Gerke, I Hassan, CP Thomas, TJ Gross, MM Monick |
Journal of leukocyte biology | 2012 |
Coordinated DNA methylation and gene expression changes in smoker alveolar macrophages: specific effects on VEGF receptor 1 expression
RA Philibert, RA Sears, LS Powers, E Nash, T Bair, AK Gerke, I Hassan, CP Thomas, TJ Gross, MM Monick |
Journal of leukocyte biology | 2012 |
Diagnóstico del déficit de alfa 1-antitripsina: limitaciones de las pruebas de laboratorio de diagnóstico rápido
F Rodríguez-Frías, B Vila-Auli, M Homs-Riba, R Vidal-Pla, JL Calpe-Calpe, R Jardi-Margalef |
Archivos de Bronconeumología | 2011 |
Severe α-1 antitrypsin deficiency caused by Q0Ourém allele: clinical features, haplotype characterization and history
LV Rodrigues, F Costa, P Marques, C Mendonça, J Rocha, S Seixas |
Clinical Genetics | 2011 |
Diagnosis of Alpha-1 Antitrypsin Deficiency: Limitations of Rapid Diagnostic Laboratory Tests
F Rodríguez-Frías, B Vila-Auli, M Homs-Riba, R Vidal-Pla, JL Calpe-Calpe, R Jardi-Margalef |
Archivos de Bronconeumología (English Edition) | 2011 |
Why has it been so difficult to prove the efficacy of alpha-1-antitrypsin replacement therapy? Insights from the study of disease pathogenesis
JA Dickens, DA Lomas |
Drug design, development and therapy | 2011 |
Alpha One Antitrypsin Deficiency: From Gene to Treatment
AM Wood, RA Stockley |
Respiration | 2007 |
A Retrospective Study and Gene Analysis of Canine Sterile Panniculitis
C YAMAGISHI, Y MOMOI, T KOBAYASHI, K IDE, K OHNO, H TSUJIMOTO, T IWASAKI |
Journal of Veterinary Medical Science | 2007 |
α1-Antitrypsin null alleles: evidence for the recurrence of the L353fsX376 mutation and a novel G→A transition in position +1 of intron IC affecting normal mRNA splicing
S Seixas, C Mendonça, F Costa, J Rocha |
Clinical Genetics | 2002 |
Diagnosis of alpha-1-antitrypsin deficiency by DNA analysis of children with liver disease
AM de TOMMASO, CL ROSSI, CA ESCANHOELA, HG SERRA, CS BERTUZZO, G HESSEL |
Arquivos de Gastroenterologia | 2001 |
Molecular mechanisms of alpha1-antitrypsin null alleles
J Lee, M Brantly |
Respiratory Medicine | 2000 |
Molecular Biology of the Lung
RA Stockley |
1999 | |
α1-Antitrypsin Nonsense Mutation Associated with a Retained Truncated Protein and Reduced mRNA
JH Lee, N Novoradovskaya, B Rundquist, J Redwine, C Saltini, M Brantly |
Molecular Genetics and Metabolism | 1998 |
An SP-B Gene Mutation Responsible for SP-B Deficiency in Fatal Congenital Alveolar Proteinosis: Evidence for a Mutation Hotspot in Exon 4
Z Lin, DE deMello, M Wallot, J Floros |
Molecular Genetics and Metabolism | 1998 |
4 α1-Antitrypsin deficiency
S Eriksson, AN Elzouki |
Bailliere's Clinical Gastroenterology | 1998 |
Pulmonary Cell Biology
RJ Mason, RG Crystal |
American journal of respiratory and critical care medicine | 1998 |
The Defective Secretion of a Naturally Occurring alpha-1-Antichymotrypsin Variant with a Frameshift Mutation
M Tsuda, Y Sei, T Ohkubo, M Yamamura, H Kamiguchi, A Akatsuka, T Tsuda, H Tachikawa, M Yamamoto, Y Shinohara |
European Journal of Biochemistry | 1996 |
Pathogenesis of liver disease in alpha1-antitrypsin deficiency
A Nemeth |
Acta Paediatrica | 1994 |
Genetic alterations at the splice junction of p53 gene in human hepatocellular carcinoma
HC Hsu, AM Huang, PL Lai, WM Chien, SY Peng, SW Lin |
Hepatology | 1994 |
Absence of alpha-1-antitrypsin (Pi Null Bellingham) and the early onset of emphysema
L Cook, ED Janus, SB néeWatts, E Tai, J Burdon |
Australian and New Zealand Journal of Medicine | 1994 |
Identification and DNA sequence analysis of 15 new alpha 1-antitrypsin variants, including two PI*Q0 alleles and one deficient PI*M allele
JP Faber, W Poller, S Weidinger, M Kirchgesser, R Schwaab, F Bidlingmaier, K Olek |
The American Journal of Human Genetics | 1994 |
Only three mutations account for almost all defective alleles causing adenine phosphoribosyltransferase deficiency in Japanese patients
N Kamatani, M Hakoda, S Otsuka, H Yoshikawa, S Kashiwazaki |
Journal of Clinical Investigation | 1992 |
Genetic variants of alpha-1-antitrypsin (AAT)
G Fabbretti, C Sergl, G Consales, G Faa, M Brisigotti, G Romeo, F Callea |
Liver | 1992 |
Biochemistry of Pulmonary Emphysema
C Grassi, J Travis, L Casali, M Luisetti |
1992 | |
Secretion of alpha-1-proteinase inhibitor requires an almost full length molecule
RM Brodbeck, JL Brown |
The Journal of biological chemistry | 1992 |
The cellular basis for liver injury in α1-antitrypsin deficiency
DH Perlmutter |
Hepatology | 1991 |
Molecular basis for hereditary antithrombin III quantitative deficiencies: a stop codon in exon IIIa and a frameshift in exon VI
S Gandrille, D Vidaud, J Emmerich, E Clauser, P Sié, JN Fiessinger, M Alhenc-Gelas, P Priollett, M Aiach |
British Journal of Haematology | 1991 |
DNA polymorphisms associated with a new ?1-antitrypsin PI Q0 variant (PI Q0riedenburg)
W Poller, JP Faber, S Weidinger, K Olek |
Human Genetics | 1991 |
Identification of intronic point mutations as an alternative mechanism for p53 inactivation in lung cancer
T Takahashi, D D'Amico, I Chiba, DL Buchhagen, JD Minna |
Journal of Clinical Investigation | 1990 |
A null deficiency allele of alpha 1-antitrypsin, QOludwigshafen, with altered tertiary structure
GC Frazier, MA Siewertsen, MH Hofker, MG Brubacher, DW Cox |
Journal of Clinical Investigation | 1990 |
Alpha 1-antitrypsin Null(isola di procida): an alpha 1-antitrypsin deficiency allele caused by deletion of all alpha 1-antitrypsin coding exons
H Takahashi, RG Crystal |
The American Journal of Human Genetics | 1990 |
Molecular basis of alpha 1-antitrypsin deficiency and emphysema associated with the alpha 1-antitrypsin Mmineral springs allele
DT Curiel, C Vogelmeier, RC Hubbard, LE Stier, RG Crystal |
Molecular and cellular biology | 1990 |
Molecular biology and respiratory disease. 7. The alpha 1 antitrypsin gene and chronic lung disease
N Kalsheker, K Morgan |
Thorax | 1990 |
Highly variable clinical course in severeα 1-antitrypsin deficiency — Use of polymerase chain reaction for the detection of rare deficiency alleles
W Poller, , K Olek |
Klinische Wochenschrift | 1990 |
Molecular characterisation of two alpha-1-antitrypsin deficiency variants: proteinase inhibitor (Pi) NullNewport (Gly115?Ser) and (Pi) Z Wrexham (Ser?19?Leu)
A Graham, NA Kalsheker, FJ Bamforth, CR Newton, AF Markham |
Human Genetics | 1990 |
Alpha-1-antitrypsin Deficiency: Accumulation or Degradation of Mutant Variants within the Hepatic Endoplasmic Reticulum
RN Sifers, MJ Finegold, SL Woo |
American journal of respiratory cell and molecular biology | 1989 |
Deletion/frameshift mutation in the ?1 null allele, PI*QObolton
GC Fraizer, M Siewertsen, TR Harrold, DW Cox |
Human Genetics | 1989 |
Molecular Basis of the Liver and Lung Disease Associated with the α1-Antitrypsin Deficiency Allele Mmalton
DT Curiel, MD Holmes, H Okayama, ML Brantly, C Vogelmeier, WD Travis, LE Stier, WH Perks, RG Crystal |
The Journal of biological chemistry | 1989 |
Molecular characterisation of three alpha-1-antitrypsin deficiency variants: proteinase inhibitor (Pi) nullcardiff (Asp256?Val); Pi Mmalton (Phe51? deletion) and Pi I (Arg39?Cys)
A Graham, NA Kalsheker, CR Newton, FJ Bamforth, SJ Powell, AF Markham |
Human Genetics | 1989 |
Verhandlungen der Deutschen Gesellschaft für Innere Medizin
B Schlegel |
1962 |